April 18, 2023
RegMed Investors’ (RMi) pre-open: support stimulates sustainability as I continue heightened analysis
April 17, 2023
RegMed Investors’ (RMi) pre-open: follow the bouncing share pricing for a potential recoil
April 14, 2023
RegMed Investors’ (RMi) pre-open: I suspect a fear trade Friday
April 13, 2023
RegMed Investors’ (RMi) pre-open: the news, pricing is under pressure
April 12, 2023
RegMed Investors’ (RMi) pre-open: CPI, or should we consider it crisis prevention and intervention
April 10, 2023
RegMed Investors’ (RMi) pre-open: sector share pricing sustainability needed
April 6, 2023
RegMed Investors’ (RMi) pre-open: Thursday will cap off a shortened trading week with the market closed for Good Friday
April 5, 2023
RegMed Investors’ (RMi) pre-open: lookin’ for love, the cell and gene therapy sector even welcomes any algos
April 4, 2023
RegMed Investors’ (RMi) pre-open: warning
April 3, 2023
RegMed Investors’ (RMi) pre-open: a new month and Q2, do you want the good or bad news?
March 30, 2023
RegMed Investors’ (RMi) pre-open: the sector gained steam for one session, on second day it’s time to be safe versus sorry
March 28, 2023
RegMed Investors’ (RMi) pre-open: the market and sector turmoil ain’t over
March 27, 2023
RegMed Investors’ (RMi) pre-open: no bad bank news will be good news as Q1/23 will come to a close this week
March 24, 2023
RegMed Investors’ (RMi) pre-open: good news, it’s Friday
March 23, 2023
RegMed Investors’ (RMi) pre-open: Bottom, bottom is it in sight?
March 22, 2023
RegMed Investors’ (RMi) pre-open: What’s on tap?
March 21, 2023
RegMed Investors’ (RMi) pre-open: what’s the range of price movements?
March 20, 2023
RegMed Investors’ (RMi) pre-open: still vulnerable and receptive to electronic trading nibbles and bites
March 17, 2023
RegMed Investors’ (RMi) pre-open: a quadruple-witching Friday
March 16, 2023
RegMed Investors’ (RMi) pre-open: will there be another Black Swan event for the cell and gene therapy sector and how soon versus when?
March 15, 2023
RegMed Investors’ (RMi) pre-open: money’s leaving share pricing due to inherent risks
March 14, 2023
RegMed Investors’ (RMi) pre-open: from the fear of the SVB scenario came
2 hours 48 min ago
RMi Pre-opening: Shovel-out the portfolio
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.